Interleukin Genetics Overview
- Year Founded
-
1986
- Status
-
Acquired/Merged
- Employees
-
14
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
1
Interleukin Genetics General Information
Description
Developer of genetic testing technology designed to adhere the needs of chronic diseases and health-related conditions. The company's genetic testing technology includes brand of genetic tests that offer clear and personalized insights to wellness and includes personalized guidance on specific diet and exercise choices, enabling patients to improve their health outcomes.
Contact Information
Website
www.ilgenetics.comCorporate Office
- 135 Beaver Street
- Waltham, MA 02452
- United States
Corporate Office
- 135 Beaver Street
- Waltham, MA 02452
- United States
Interleukin Genetics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Interleukin Genetics Comparisons
Industry
Financing
Details
Interleukin Genetics Competitors (3)
One of Interleukin Genetics’s 3 competitors is Element Biosciences, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Element Biosciences | Venture Capital-Backed | San Diego, CA | ||||
| QuantuMDx | Venture Capital-Backed | Newcastle Upon Tyne, United Kingdom | ||||
| Llusern Scientific | Venture Capital-Backed | Cardiff, United Kingdom |
Interleukin Genetics Patents
Interleukin Genetics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018130670-A1 | Methods and kits for treating cardiovascular disease | Inactive | 12-Jan-2017 | ||
| AU-2017207341-A1 | Methods for predicting response to treatment | Inactive | 12-Jan-2016 | ||
| CA-3011363-A1 | Methods for predicting response to treatment | Pending | 12-Jan-2016 | ||
| WO-2017123696-A1 | Methods for predicting response to treatment | Inactive | 12-Jan-2016 | ||
| JP-2017121237-A | Improved method and kit for determining severity and progression of periodontal disease | Active | 09-Dec-2010 | C12Q1/6883 |
Interleukin Genetics Signals
Interleukin Genetics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Interleukin Genetics Acquisitions (1)
Interleukin Genetics’s most recent deal was a Merger/Acquisition with Alan James Group. The deal was made on 01-Sep-2006.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alan James Group | 01-Sep-2006 | Merger/Acquisition | Drug Delivery |
Interleukin Genetics Exits (1)
Interleukin Genetics’s most recent exit was on 01-Sep-2006 from Alan James Group. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Alan James Group | 01-Sep-2006 | Completed |
|
Interleukin Genetics FAQs
-
When was Interleukin Genetics founded?
Interleukin Genetics was founded in 1986.
-
Where is Interleukin Genetics headquartered?
Interleukin Genetics is headquartered in Waltham, MA.
-
What is the size of Interleukin Genetics?
Interleukin Genetics has 14 total employees.
-
What industry is Interleukin Genetics in?
Interleukin Genetics’s primary industry is Laboratory Services (Healthcare).
-
Is Interleukin Genetics a private or public company?
Interleukin Genetics is a Private company.
-
What is Interleukin Genetics’s current revenue?
The current revenue for Interleukin Genetics is .
-
How much funding has Interleukin Genetics raised over time?
Interleukin Genetics has raised $45.8M.
-
Who are Interleukin Genetics’s investors?
Bay City Capital, New Enterprise Associates, Nexus Life Science Partners, and Pyxis Innovations have invested in Interleukin Genetics.
-
Who are Interleukin Genetics’s competitors?
Element Biosciences, QuantuMDx, and Llusern Scientific are competitors of Interleukin Genetics.
-
When was Interleukin Genetics acquired?
Interleukin Genetics was acquired on 22-Nov-2017.
-
Who acquired Interleukin Genetics?
Interleukin Genetics was acquired by Seaport Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process